• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pathway-based personalized analysis of cancer.基于通路的癌症个性化分析。
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6388-93. doi: 10.1073/pnas.1219651110. Epub 2013 Apr 1.
2
FREQUENT SUBGRAPH MINING OF PERSONALIZED SIGNALING PATHWAY NETWORKS GROUPS PATIENTS WITH FREQUENTLY DYSREGULATED DISEASE PATHWAYS AND PREDICTS PROGNOSIS.个性化信号通路网络的频繁子图挖掘对疾病通路频繁失调的患者进行分组并预测预后。
Pac Symp Biocomput. 2017;22:402-413. doi: 10.1142/9789813207813_0038.
3
Uncovering the subtype-specific temporal order of cancer pathway dysregulation.揭示癌症通路失调的亚型特异性时间顺序。
PLoS Comput Biol. 2019 Nov 11;15(11):e1007451. doi: 10.1371/journal.pcbi.1007451. eCollection 2019 Nov.
4
Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.从横断面突变数据中同时推断癌症通路和肿瘤进展
J Comput Biol. 2015 Jun;22(6):510-27. doi: 10.1089/cmb.2014.0161. Epub 2015 Mar 18.
5
Pathway Activation Analysis for Pan-Cancer Personalized Characterization Based on Riemannian Manifold.基于黎曼流形的泛癌个性化特征通路激活分析
Int J Mol Sci. 2024 Apr 17;25(8):4411. doi: 10.3390/ijms25084411.
6
PenDA, a rank-based method for personalized differential analysis: Application to lung cancer.基于排名的个性化差异分析方法 PenDA:在肺癌中的应用。
PLoS Comput Biol. 2020 May 11;16(5):e1007869. doi: 10.1371/journal.pcbi.1007869. eCollection 2020 May.
7
Identifying cooperating cancer driver genes in individual patients through hypergraph random walk.通过超图随机游走在个体患者中识别协同致癌驱动基因。
J Biomed Inform. 2024 Sep;157:104710. doi: 10.1016/j.jbi.2024.104710. Epub 2024 Aug 17.
8
System-scale network modeling of cancer using EPoC.使用 EPoC 进行癌症的系统级网络建模。
Adv Exp Med Biol. 2012;736:617-43. doi: 10.1007/978-1-4419-7210-1_37.
9
Efficient algorithms to discover alterations with complementary functional association in cancer.高效算法发现癌症中具有互补功能关联的改变。
PLoS Comput Biol. 2019 May 23;15(5):e1006802. doi: 10.1371/journal.pcbi.1006802. eCollection 2019 May.
10
Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.基于生物信息学分析鉴定胶质母细胞瘤中的潜在关键基因和分子机制。
Mol Med Rep. 2020 Aug;22(2):859-869. doi: 10.3892/mmr.2020.11160. Epub 2020 May 20.

引用本文的文献

1
LaGrACE: estimating gene program dysregulation with latent regulatory network.LaGrACE:利用潜在调控网络估计基因程序失调
Mol Syst Biol. 2025 Jun 30. doi: 10.1038/s44320-025-00115-3.
2
Cell type proportions rather than DNA methylation in the cord blood show significant associations with severe preeclampsia.脐带血中的细胞类型比例而非DNA甲基化与重度子痫前期存在显著关联。
medRxiv. 2025 Jun 10:2025.06.09.25329270. doi: 10.1101/2025.06.09.25329270.
3
Signalomics for molecular tumor boards and precision oncology of breast and gynecological cancers.用于分子肿瘤委员会以及乳腺癌和妇科癌症精准肿瘤学的信号组学。
Mol Syst Biol. 2025 Jun 9. doi: 10.1038/s44320-025-00125-1.
4
Longitudinal pathway analysis using structural information with case studies in early type 1 diabetes.利用结构信息进行纵向通路分析及1型糖尿病早期病例研究。
Sci Rep. 2025 May 2;15(1):15393. doi: 10.1038/s41598-025-98492-0.
5
AEGAN-Pathifier: a data augmentation method to improve cancer classification for imbalanced gene expression data.AEGAN-Pathifier:一种用于改善不平衡基因表达数据的癌症分类的数据增强方法。
BMC Bioinformatics. 2024 Dec 27;25(1):392. doi: 10.1186/s12859-024-06013-z.
6
Subtype-specific transcription factors affect polyamine metabolism and the tumor microenvironment in breast cancer.亚型特异性转录因子影响乳腺癌中的多胺代谢和肿瘤微环境。
Cancer Innov. 2024 Dec 2;4(1):e138. doi: 10.1002/cai2.138. eCollection 2025 Feb.
7
DeePathNet: A Transformer-Based Deep Learning Model Integrating Multiomic Data with Cancer Pathways.DeePathNet:一种基于Transformer的深度学习模型,整合多组学数据与癌症通路。
Cancer Res Commun. 2024 Dec 1;4(12):3151-3164. doi: 10.1158/2767-9764.CRC-24-0285.
8
Current approaches and outstanding challenges of functional annotation of metabolites: a comprehensive review.当前代谢物功能注释的方法和突出挑战:全面综述。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae498.
9
Withaferin A decreases glycolytic reprogramming in breast cancer.醉茄素 A 可降低乳腺癌中的糖酵解重编程。
Sci Rep. 2024 Oct 4;14(1):23147. doi: 10.1038/s41598-024-72221-5.
10
Distinct pathway activities are associated with prognosis and response to bortezomib-containing treatment in MCL1-M based molecular subtypes of multiple myeloma.在基于MCL1-M的多发性骨髓瘤分子亚型中,不同的信号通路活性与预后以及含硼替佐米治疗的反应相关。
Ann Hematol. 2024 Dec;103(12):5495-5510. doi: 10.1007/s00277-024-06009-y. Epub 2024 Sep 21.

本文引用的文献

1
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.高 CXCL13-CXCR5 信使 RNA 表达的高危早期 HER2 阳性乳腺癌患者的转归改善。
Clin Breast Cancer. 2012 Jun;12(3):183-93. doi: 10.1016/j.clbc.2012.03.006.
2
Syndecan-4 and fibronectin in osteosarcoma.黏附素-4 和纤维连接蛋白在骨肉瘤中的表达。
Pathology. 2012 Jun;44(4):325-30. doi: 10.1097/PAT.0b013e328353447b.
3
Molecular classification of prostate cancer using curated expression signatures.基于经整理的表达特征对前列腺癌进行分子分类。
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21276-81. doi: 10.1073/pnas.1117029108. Epub 2011 Nov 28.
4
KEGG for integration and interpretation of large-scale molecular data sets.KEGG 用于整合和解释大规模分子数据集。
Nucleic Acids Res. 2012 Jan;40(Database issue):D109-14. doi: 10.1093/nar/gkr988. Epub 2011 Nov 10.
5
A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression.TLN-4601 在初诊胶质母细胞瘤患者中 Ras-MAPK 信号通路抑制剂的 II 期研究
J Neurooncol. 2012 Apr;107(2):343-9. doi: 10.1007/s11060-011-0747-6. Epub 2011 Nov 3.
6
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.长链非编码 RNA HOTAIR 调节多梳依赖的染色质修饰,并与结直肠癌的不良预后相关。
Cancer Res. 2011 Oct 15;71(20):6320-6. doi: 10.1158/0008-5472.CAN-11-1021. Epub 2011 Aug 23.
7
Pathway analysis of expression data: deciphering functional building blocks of complex diseases.表达数据的通路分析:解读复杂疾病的功能构建模块。
PLoS Comput Biol. 2011 May;7(5):e1002053. doi: 10.1371/journal.pcbi.1002053. Epub 2011 May 26.
8
Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.外显子微阵列分析鉴定的结直肠癌转录组不稳定性:与剪接因子表达水平和患者生存的关联。
Genome Med. 2011 May 27;3(5):32. doi: 10.1186/gm248.
9
Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes?两种基于机器学习的乳腺癌预后标志物是否捕捉到相同的生物学过程?
PLoS One. 2011 Mar 14;6(3):e17795. doi: 10.1371/journal.pone.0017795.
10
Making sense of cancer genomic data.解析癌症基因组数据。
Genes Dev. 2011 Mar 15;25(6):534-55. doi: 10.1101/gad.2017311.

基于通路的癌症个性化分析。

Pathway-based personalized analysis of cancer.

机构信息

Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot 76100, Israel.

出版信息

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6388-93. doi: 10.1073/pnas.1219651110. Epub 2013 Apr 1.

DOI:10.1073/pnas.1219651110
PMID:23547110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3631698/
Abstract

We introduce Pathifier, an algorithm that infers pathway deregulation scores for each tumor sample on the basis of expression data. This score is determined, in a context-specific manner, for every particular dataset and type of cancer that is being investigated. The algorithm transforms gene-level information into pathway-level information, generating a compact and biologically relevant representation of each sample. We demonstrate the algorithm's performance on three colorectal cancer datasets and two glioblastoma multiforme datasets and show that our multipathway-based representation is reproducible, preserves much of the original information, and allows inference of complex biologically significant information. We discovered several pathways that were significantly associated with survival of glioblastoma patients and two whose scores are predictive of survival in colorectal cancer: CXCR3-mediated signaling and oxidative phosphorylation. We also identified a subclass of proneural and neural glioblastoma with significantly better survival, and an EGF receptor-deregulated subclass of colon cancers.

摘要

我们介绍了一种名为 Pathifier 的算法,它可以根据表达数据为每个肿瘤样本推断途径失调分数。该分数是针对每个特定数据集和正在研究的癌症类型以特定于上下文的方式确定的。该算法将基因水平的信息转换为途径水平的信息,为每个样本生成紧凑且与生物学相关的表示形式。我们在三个结直肠癌数据集和两个胶质母细胞瘤多形性数据集上展示了该算法的性能,并表明我们的多途径表示是可重复的,保留了大部分原始信息,并允许推断复杂的生物学意义信息。我们发现了几个与胶质母细胞瘤患者生存显著相关的途径,以及两个与结直肠癌生存相关的评分:CXCR3 介导的信号和氧化磷酸化。我们还鉴定了具有显著更好生存的神经原性和神经胶质母细胞瘤的亚类,以及 EGF 受体失调的结肠癌细胞亚类。